Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

ShockWave Medical, Inc. SWAV NASDAQ

NASDAQ Global Select • Healthcare • Medical - Devices • US • USD

SharesGrow Score
60/100
4/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$258.17
-22.9%

ShockWave Medical, Inc. (SWAV) is a Medical - Devices company in the Healthcare sector, currently trading at $334.75. It has a SharesGrow Score of 60/100, indicating a above average investment profile with 4 out of 7 criteria passed.

Analyst consensus target is SWAV = $258 (-22.9% upside).

Financials: revenue is $730M, +135.1%/yr average growth. Net income is $147M, growing at +839.5%/yr. Net profit margin is 20.2% (strong). Gross margin is 86.9% (+17.9 pp trend).

Balance sheet: total debt is $771M against $669M equity (Debt-to-Equity (D/E) ratio 1.15, moderate). Current ratio is 11.76 (strong liquidity). Debt-to-assets is 49.2%. Total assets: $1.6B.

Analyst outlook: 4 / 13 analysts rate SWAV as buy (31%) — mixed sentiment.

SharesGrow 7-Criteria breakdown: Value 12/100 (Fail), Growth 100/100 (Pass), Past 50/100 (Partial), Health 83/100 (Pass), Moat 76/100 (Pass), Future 16/100 (Fail), Income 85/100 (Pass).

$258.17
▼ 22.88% Downside
Average Price Target
Based on 13 Wall Street analysts offering 12-month price targets for ShockWave Medical, Inc., the average price target is $258.17, with a high forecast of $360.00, and a low forecast of $175.00.
Highest Price Target
$360.00
Average Price Target
$258.17
Lowest Price Target
$175.00

SWAV SharesGrow Score Overview

60/100
SharesGrow Score
Above average fundamentals
View full scorecard →
VALUE 12/100
Valuation — P/E, PEG, Forward PEG
GROWTH 100/100
Financials — average growth
PAST 50/100
strong — trend
HEALTH 83/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 76/100
Gross margin is + market cap
FUTURE 16/100
Analyst outlook — as buy
INCOME 85/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — SWAV

✗
VALUE Fail
12/100
SWAV trades at a trailing Price-to-Earnings (P/E) of N/A (S&P 500 average ~25). Analyst consensus target is $258, implying -22.9% from the current price $335. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
✓
GROWTH Pass
100/100
SWAV: +135.1%/yr revenue is, +839.5%/yr Net income is average growth. > 5%/yr — strong. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
~
PAST Partial
50/100
SWAV: 2 / 4 years profitable. weak. Score = 2 / 4 × 100. ≥ 80 = Pass.
View details →
✓
HEALTH Pass
83/100
Balance sheet SWAV: Debt-to-Equity (D/E) ratio 1.15 (moderate), Current ratio is 11.76 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
✓
MOAT Pass
76/100
SWAV: Gross margin is 86.9% (+17.9 pp trend), $13B market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 76/100. ≥ 70 = Pass.
View details →
✗
FUTURE Fail
16/100
Analyst outlook: 4 / 13 analysts rate SWAV as buy (31%). Analyst consensus target is $258 (-22.9% upside). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
✓
INCOME Pass
85/100
SWAV: Net profit margin is 20.2%. healthy (≥15%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range157.0-334.9
Volume3.95M
Avg Volume (30D)1.25M
Market Cap$12.57B
Beta (1Y)0.88
Share Statistics
EPS (TTM)4.01
Shares Outstanding$36.71M
IPO Date2019-03-07
Employees1,468
CEODouglas E. Godshall
Financial Highlights & Ratios
Revenue (TTM)$730.23M
Gross Profit$634.84M
EBITDA$176.35M
Net Income$147.28M
Operating Income$165.99M
Total Cash$990.55M
Total Debt$770.61M
Net Debt$442.19M
Total Assets$1.57B
Price / Earnings (P/E)83.5
Price / Sales (P/S)17.21
Analyst Forecast
1Y Price Target$239.50
Target High$360.00
Target Low$175.00
Upside-28.5%
Rating ConsensusHold
Analysts Covering13
Buy 31% Hold 62% Sell 8%
Company Info
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS82489T1043

Price Chart

Track all markets on TradingView
SWAV
ShockWave Medical, Inc. ↗  ·  NASDAQ Global Select
Healthcare • Medical - Devices
157.00 52WK RANGE 334.90

People Also View

SYK
SYK
Stryker Corporation
$345.88
-0.39%
 EW
EW
Edwards Lifesciences Corporation
$78.20
+0.10%
 DXCM
DXCM
DexCom, Inc.
$62.95
-0.27%
 PODD
PODD
Insulet Corporation
$201.49
+1.86%
 ALGN
ALGN
Align Technology, Inc.
$184.69
+2.23%
 PEN
PEN
Penumbra, Inc.
$332.17
+0.21%
 MASI
MASI
Masimo Corporation
$178.39
-0.04%
 NARI
NARI
Inari Medical, Inc.
$79.97
+0.00%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message